中文名称: | Ko143 hydrate | ||||
---|---|---|---|---|---|
英文名称: | Ko143 hydrate | ||||
别名: | (3S,6S,12aS)-1,2,3,4,6,7,12,12a-八氢-9-甲氧基-6-(2-甲基丙基)-1,4-二氧代吡嗪并[1',2':1,6]吡啶并[3,4-b]吲哚-3-丙酸叔丁酯 tert-Butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)propanoate | ||||
CAS No: | 461054-93-3 | 分子式: | C26H35N3O5 | 分子量: | 469.57 |
CAS No: | 461054-93-3 | ||||
分子式: | C26H35N3O5 | ||||
分子量: | 469.57 |
基本信息
产品编号: |
K10127 |
||||
产品名称: |
Ko143 hydrate |
||||
CAS: |
461054-93-3 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
469.57 |
-20℃ |
1个月 |
||
化学名: |
Ko-143 hydrate,(3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1′,2′:1,6]pyrido[3,4- b]indole-3-propanoic acid 1,1-dimethylethyl ester hydrate |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
94mg/mL (200.18mM) |
|||
Ethanol |
94mg/mL (200.18mM) |
||||
Water |
Insoluble |
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.1296mL |
10.6480 mL |
21.2961mL |
5mM |
0.4259mL |
2.1296 mL |
4.2592mL |
10mM |
0.2130mL |
1.0648 mL |
2.1296mL |
生物活性
产品描述 |
一种有效且选择性的ATP结合盒亚家族G成员2(ABCG2/BCRP)抑制剂。 |
靶点 |
EC90:26nM (BCRP) |
体外研究 |
Ko143 (10nM) significantly decreases (2.5-fold) the IC50 of MTX for HEK G2 cells and mouse G2 cells.Ko143 (1-100μM) metabolite does not inhibit the function of ABC Transporters.Reversal of drug resistance in SKF 104864A-selected mouse MEF3.8/T6400 cells and human IGROV1/T8 cells by FTC analogue Ko143.Ko143 is applied at zero,one,or eight times the EC90 concentration of 25nM.Ko143 inhibits BCRP-mediated transport of ZD 4522 in Madin-Darby Canine Kidney (MDCK) 2-BCRP421CC (wild type) cells and MDCK2-BCRP421AA (mutant type) cells. |
体内研究 |
Ko143 (10mg/kg,p.o.) increases the oral availability of SKF 104864A in mice.Ko143 significantly affects the pharmacokinetics of ZD 4522 in rats. |
推荐实验方法(仅供参考)
细胞实验: |
|
cells are plated at 400 or 1000/well in 96-well plates the night before addition of drugs.A concentration series of drug is applied along one plate axis and left for the duration of the assay.Plates are harvested after 4-5 days while untreated wells are still subconfluent.Relative cell proliferation is quantified with CyQuant or Sybr Green I fluorescent nucleic acid stains.Assays with human cell lines are performed in the presence of 0.1μm PSC833 to inhibit confounding P-gp activity. |
动物实验: |
|
Oral toxicity of FTC analogues in mice is tested by mixing 50mg/mL stocks in DMSO 1:1 with Tween 80 (polyoxyethylene sorbitan mono-oleate) and diluting with 5% w/v glucose such that the final volume administered by oral gavage is 10μL/g of body weight.Pairs of mice are administered oral doses of 50mg/kg Ko132,Ko134,Ko143,or vehicle under light methoxyflurane anesthesia.Final tests of 50mg/kg Ko134 or Ko143 are performed on additional pairs of unanesthetized animals to observe any behavioral effects.Further,another pair of mice receive the higher dose of 100mg/kg Ko134.For i.p.toxicity tests,the FTC analogue stocks in DMSO are dispersed in at least 10 volumes of sterile corn oil such that the injected volume is 5μL/g of body weight.After pilot tests at lower doses show no adverse effects,mice (4 per group) are administered vehicle or 10mg/kg i.p.of Ko132,Ko134,or Ko143.The mice are observed continuously during the first hour after administration and then at increasing intervals for 2 weeks,after which they are sacrificed for histological examination of major organs and structures including brain,salivary glands,heart,lungs,liver,adrenal glands,kidneys,urinary tract,spleen,thymus,bone marrow,pancreas,stomach,intestines,cecum,colon,testes,epididymus,skin,head,trunk,and limbs. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )